Dheeraj A, Marques F, Tailor D, Bermudez A, Resendez A, Pandrala M
Cell Rep Med. 2024; 5(5):101552.
PMID: 38729158
PMC: 11148772.
DOI: 10.1016/j.xcrm.2024.101552.
Quan C, Wu Z, Xiong J, Li M, Fu Y, Su J
Exp Hematol Oncol. 2023; 12(1):100.
PMID: 38037159
PMC: 10687910.
DOI: 10.1186/s40164-023-00462-7.
Sun X, Gao C, Xu X, Li M, Zhao X, Wang Y
EMBO Rep. 2023; 24(9):e56230.
PMID: 37489617
PMC: 10481664.
DOI: 10.15252/embr.202256230.
Yin Q, Zheng M, Luo Q, Jiang D, Zhang H, Chen C
Cells. 2022; 11(7).
PMID: 35406781
PMC: 8997642.
DOI: 10.3390/cells11071217.
Ushijima M, Shiota M, Matsumoto T, Kashiwagi E, Inokuchi J, Eto M
Cancer Sci. 2022; 113(5):1731-1738.
PMID: 35118769
PMC: 9128173.
DOI: 10.1111/cas.15280.
Research advances in the role and pharmaceuticals of ATP-binding cassette transporters in autoimmune diseases.
Yu J, Chen H, Xu J, Zhou P
Mol Cell Biochem. 2022; 477(4):1075-1091.
PMID: 35034257
DOI: 10.1007/s11010-022-04354-y.
YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
Cui Q, Wang C, Liu S, Du R, Tian S, Chen R
Cell Cycle. 2021; 20(22):2413-2427.
PMID: 34709966
PMC: 8794528.
DOI: 10.1080/15384101.2021.1985771.
YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level.
Delicato A, Montuori E, Angrisano T, Pollice A, Calabro V
Genes (Basel). 2021; 12(10).
PMID: 34680946
PMC: 8535809.
DOI: 10.3390/genes12101551.
A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.
Alkrekshi A, Wang W, Rana P, Markovic V, Sossey-Alaoui K
Cell Signal. 2021; 85:110073.
PMID: 34224843
PMC: 8878385.
DOI: 10.1016/j.cellsig.2021.110073.
Phosphorylation of the Regulators, a Complex Facet of NF-κB Signaling in Cancer.
Motolani A, Martin M, Sun M, Lu T
Biomolecules. 2020; 11(1).
PMID: 33375283
PMC: 7823564.
DOI: 10.3390/biom11010015.
circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/β-catenin feedback loop promotes bladder cancer progression.
Tong L, Yang H, Xiong W, Tang G, Zu X, Qi L
Cancer Sci. 2020; 112(4):1429-1442.
PMID: 33314480
PMC: 8019231.
DOI: 10.1111/cas.14774.
Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression.
Shiota M, Sekino Y, Tsukahara S, Abe T, Kinoshita F, Imada K
Cancer Sci. 2020; 112(1):323-330.
PMID: 33064355
PMC: 7780013.
DOI: 10.1111/cas.14695.
Validated prognostic significance of YB-1 genetic variation in metastatic prostate cancer.
Shiota M, Narita S, Habuchi T, Eto M
Pharmacogenomics J. 2020; 21(1):102-105.
PMID: 32963329
DOI: 10.1038/s41397-020-00188-3.
Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).
Lou L, Wang J, Lv F, Wang G, Li Y, Xing L
Cell Oncol (Dordr). 2020; 44(1):109-133.
PMID: 32894437
DOI: 10.1007/s13402-020-00556-y.
Activation of RSK by phosphomimetic substitution in the activation loop is prevented by structural constraints.
Somale D, Di Nardo G, di Blasio L, Puliafito A, Vara-Messler M, Chiaverina G
Sci Rep. 2020; 10(1):591.
PMID: 31953410
PMC: 6969211.
DOI: 10.1038/s41598-019-56937-3.
Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.
Xu W, Ma Y, Ma H, Shi L, Mu H, Ou W
Cell Cycle. 2019; 18(24):3472-3490.
PMID: 31713447
PMC: 6927700.
DOI: 10.1080/15384101.2019.1689474.
Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.
Murugesan S, Yadav B, Maurya P, Chaudhary A, Singh S, Mani A
J Biosci. 2019; 44(2).
PMID: 31180040
Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer.
Kuwano M, Shibata T, Watari K, Ono M
Cancer Sci. 2019; 110(5):1536-1543.
PMID: 30903644
PMC: 6500994.
DOI: 10.1111/cas.14006.
Y-box binding protein YBX1 and its correlated genes as biomarkers for poor outcomes in patients with breast cancer.
Shibata T, Tokunaga E, Hattori S, Watari K, Murakami Y, Yamashita N
Oncotarget. 2019; 9(98):37216-37228.
PMID: 30647855
PMC: 6324687.
DOI: 10.18632/oncotarget.26469.
Cold shock proteins: from cellular mechanisms to pathophysiology and disease.
Lindquist J, Mertens P
Cell Commun Signal. 2018; 16(1):63.
PMID: 30257675
PMC: 6158828.
DOI: 10.1186/s12964-018-0274-6.